Quote:
Originally Posted by Chris
Yes, I'm sure the EMA was absolutely at the beck and call of No.10 when it came to announcing findings over this.
|
The EMA have announced their findiings today.
Quote:
EMA confirms overall benefit-risk remains positive
EMA’s safety committee (PRAC) has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca).
In reaching its conclusion, the committee took into consideration all currently available evidence, including the advice from an ad hoc expert group.
|
https://www.ema.europa.eu/en/news/as...lots-low-blood